{"id":439798,"date":"2021-02-19T08:03:14","date_gmt":"2021-02-19T13:03:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=439798"},"modified":"2021-02-19T08:03:14","modified_gmt":"2021-02-19T13:03:14","slug":"usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/","title":{"rendered":"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WEST PALM BEACH, FL, Feb.  19, 2021  (GLOBE NEWSWIRE) &#8212; USA EQUITIES CORP. (OTCQB: USAQ) (the \u201cCompany,\u201d \u201cwe,\u201d or \u201cour\u201d) is focused on enabling primary care physicians (PCP\u2019s) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease through reimbursable point of care and SaaS procedures. The Company is excited to announce today that five of its medical advisory board members will be presenting at the inaugural University of Miami Allergy Diagnostics and Allergen Immunotherapy Virtual CME event on March 13, 2021. Assistant Professor of Otolaryngology, Bj\u00f6rn Herman, MD, FACS, Fredric W. Pullen, II MD, FACS, Professor, vol., Otolaryngology, both at the University of Miami Miller School of Medicine, Dr. Frank Lichtenberger, MD, PhD, board certified allergist and Immunologist, Marcos Sanchez-Gonzalez MD, PhD and Syed Rizvi PhD, will be presenting at the conference, along with a panel of their esteemed colleagues.<\/p>\n<p align=\"justify\">\u201cWe\u2019re thrilled that the leaders of our medical advisory board and experts in the field are participating in this unique live virtual conference. At USAQ, we champion education and prioritize, equipping physicians with the tools they need to improve clinical outcomes and sustain their practices with new ancillary services and revenue streams, including continuing medical education,\u201d said Troy Grogan, President and CEO at USA Equities Corp.<\/p>\n<p align=\"justify\">According to the University of Miami\u2019s description of the CME workshop, practitioners can expect \u201cthe training they need to diagnose, treat, and manage patients with noncomplex, non-life-threatening allergies. Physicians, nurses, nurse practitioners, physician assistants and other medical professionals who are not board-certified in allergy and immunology will develop evidence-based skills, knowledge, and confidence in the field of allergy and immunology.\u201d<\/p>\n<p align=\"justify\">\u201cAs a member of USAQ\u2019s advisory board, it\u2019s important to see companies emerge that prioritize the future of medicine. USAQ equips physicians with the digital tools and point of care services such as allergy testing and treatment products they desperately need to treat a wider variety of clinical issues, better serve their patients, provide opportunities for continuing education, and encourage the adoption and availability of technology,\u201d said Fred Pullen MD, Medical Adviser at USAQ.<\/p>\n<p align=\"justify\">Physicians and other health care providers can find more information about the University of Miami Allergy Diagnostics &amp; Allergen Immunotherapy CME event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Svu880id3_Xv2LqZR9YEZVv7WySRBiVbsNxJgk6ytU4y3Igiu1YWNHRjYNqadTJPyNk3LFUBwtEe8SVu5Jxlub_Ci5w3oRIENbxFsKiJeok=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.miami.edu\/allergy<\/u><\/a><\/p>\n<p align=\"justify\">\n        <strong>About USA Equities Corp (OTCQB: USAQ)<\/strong>\n      <\/p>\n<p align=\"justify\">On December 20, 2019 USA Equities Corp completed a share exchange whereby it acquired Medical Practice Income, Inc. (MPI). The Company is focused on value-based healthcare solutions, clinical informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. The Company\u2019s products are intended to allow the general practice physician to increase his revenues by cost effectively diagnosing and treating chronic diseases generally referred to specialists. The Company\u2019s products and information service portfolio are directed towards prevention, early detection, management, and reversal of cardio-metabolic and other chronic diseases. Our principal objectives are to develop proprietary software tools, devices, and approaches, providing more granular, timely, and specific clinical decision-making information for practicing physicians and other health care providers to address todays obese, diabetic and cardiovascular disease population. The Company is located in West Palm Beach, Florida. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X6L81EPVwRojGghb5_QoHkYIT_6yt64Cb51IN62wnDqfAUMgT1H6_zA_TKL9PL-qCw31_tvhFK56rLebV6frfw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.USAQCorp.com<\/u><\/a><\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Certain matters discussed in this press release are \u2018forward-looking statements\u2019 intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company\u2019s statements regarding trends in the marketplace, future revenues, future products and potential future results and acquisitions, are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as \u2018may\u2019, \u2018could\u2019, \u2018believes\u2019, \u2018estimates\u2019, \u2018targets\u2019, \u2018expects\u2019, or \u2018intends\u2019 and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company\u2019s control. The factors discussed herein and expressed from time to time in the Company\u2019s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Investor &amp; Media Contact:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Olivia Giamanco<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">USA Equities Corp<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">(929) 379-6503<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <a href=\"mailto:IR@USAQCORP.COM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n              <u>IR@USAQCORP.COM<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/597a38ac-72a9-4b63-b944-6f075e5a292e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WEST PALM BEACH, FL, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; USA EQUITIES CORP. (OTCQB: USAQ) (the \u201cCompany,\u201d \u201cwe,\u201d or \u201cour\u201d) is focused on enabling primary care physicians (PCP\u2019s) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease through reimbursable point of care and SaaS procedures. The Company is excited to announce today that five of its medical advisory board members will be presenting at the inaugural University of Miami Allergy Diagnostics and Allergen Immunotherapy Virtual CME event on March 13, 2021. Assistant Professor of Otolaryngology, Bj\u00f6rn Herman, MD, FACS, Fredric W. Pullen, II MD, FACS, Professor, vol., Otolaryngology, both at the University of Miami Miller School of Medicine, Dr. Frank Lichtenberger, MD, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-439798","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WEST PALM BEACH, FL, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; USA EQUITIES CORP. (OTCQB: USAQ) (the \u201cCompany,\u201d \u201cwe,\u201d or \u201cour\u201d) is focused on enabling primary care physicians (PCP\u2019s) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease through reimbursable point of care and SaaS procedures. The Company is excited to announce today that five of its medical advisory board members will be presenting at the inaugural University of Miami Allergy Diagnostics and Allergen Immunotherapy Virtual CME event on March 13, 2021. Assistant Professor of Otolaryngology, Bj\u00f6rn Herman, MD, FACS, Fredric W. Pullen, II MD, FACS, Professor, vol., Otolaryngology, both at the University of Miami Miller School of Medicine, Dr. Frank Lichtenberger, MD, &hellip; Continue reading &quot;USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-19T13:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference\",\"datePublished\":\"2021-02-19T13:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/\"},\"wordCount\":777,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/\",\"name\":\"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==\",\"datePublished\":\"2021-02-19T13:03:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/","og_locale":"en_US","og_type":"article","og_title":"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference - Market Newsdesk","og_description":"WEST PALM BEACH, FL, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; USA EQUITIES CORP. (OTCQB: USAQ) (the \u201cCompany,\u201d \u201cwe,\u201d or \u201cour\u201d) is focused on enabling primary care physicians (PCP\u2019s) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease through reimbursable point of care and SaaS procedures. The Company is excited to announce today that five of its medical advisory board members will be presenting at the inaugural University of Miami Allergy Diagnostics and Allergen Immunotherapy Virtual CME event on March 13, 2021. Assistant Professor of Otolaryngology, Bj\u00f6rn Herman, MD, FACS, Fredric W. Pullen, II MD, FACS, Professor, vol., Otolaryngology, both at the University of Miami Miller School of Medicine, Dr. Frank Lichtenberger, MD, &hellip; Continue reading \"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-19T13:03:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference","datePublished":"2021-02-19T13:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/"},"wordCount":777,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/","name":"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==","datePublished":"2021-02-19T13:03:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NTk3OCMzOTg0ODE5IzUwMDA3MTA3NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/usa-equities-corp-usaq-announces-advisory-board-leadership-for-university-of-miamis-allergy-diagnostics-allergen-immunotherapy-cme-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"USA Equities Corp (USAQ) Announces Advisory Board Leadership for University of Miami\u2019s Allergy Diagnostics &amp; Allergen Immunotherapy CME Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/439798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=439798"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/439798\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=439798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=439798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=439798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}